Strong shareholder support at Zhengye Biotechnology (ZYBT) 2026 annual meeting

Rhea-AI Filing Summary

Zhengye Biotechnology Holding Limited reported the results of its Annual General Meeting of Shareholders held on March 24, 2026 in Jilin City, China, with virtual participation also available.

The company had 47,391,376 ordinary shares outstanding as of the February 12, 2026 record date, each carrying one vote. A quorum was achieved, with holders of 43,133,362 ordinary shares represented in person or by proxy.

Shareholders voted on five numbered resolutions, all of which received strong support. For example, Resolution No. 1 received 43,092,532 votes for, 24,730 against, and 16,100 abstentions. The other resolutions (Nos. 2–5) showed similarly high levels of approval, confirming shareholder backing for the company’s proposals.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2026

Commission File Number: 001-42450

Zhengye Biotechnology Holding Limited

No. 1 Lianmeng Road, Jilin Economic & Technical Development Zone

Jilin City, Jilin Province, China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒      Form 40-F ☐

 Results of Zhengye Biotechnology Holding Limited’s Annual General Meeting of Shareholders

The Annual General Meeting of Shareholders (the “Meeting”) of Zhengye Biotechnology Holding Limited (the “Company”) was held at No. 1 Lianmeng Road, Jilin Economic & Technical Development Zone Jilin City, Jilin Province, China, on March 24, 2026, at 8:00 a.m. ET, with the ability given to the shareholders to join virtually via live audio webcast at www.virtualshareholdermeeting.com/ZYBT2026.

At the close of business on February 12, 2026, the record date for the determination of shareholders entitled to vote at the Meeting, there were 47,391,376ordinary shares (the “Ordinary Shares”) outstanding, each share being entitled to one (1) vote, constituting all of the outstanding voting securities of the Company. At the Meeting, the holders of 43,133,362 Ordinary Shares of the Company, representing 43,133,362 votes, were represented in person or by proxy, constituting a quorum.

At the Meeting, the shareholders of the Company adopted the following resolutions:

1. An ordinary resolution to approve the election of two director candidates;

2. An ordinary resolution to approve the re-election of certain current directors;

3. An ordinary resolution to approve the share reclassification;

4. An ordinary resolution to approve the share consolidation; and

5. A special resolution to approve the adoption of the new memorandum and articles of association of the Company.

The results of the vote at the Meeting for the resolutions were as follows:

*		For				Against				Abstain
No. 1			43,092,532				24,730				16,100
No. 2			43,090,399				26,743				16,220
No. 3			43,023,158				90,024				20,180
No. 4			43,088,491				44,771				100
No. 5			43,025,957				91,275				16,130

* The numbers in this column correspond to the resolutions enumerated in the third paragraph of this report.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: March 24, 2026

	Zhengye Biotechnology Holding Limited
	By:	/s/ Songlin Song
	Name:	Songlin Song
	Title:	Chief Executive Officer

2

FAQ

When did Zhengye Biotechnology (ZYBT) hold its 2026 Annual General Meeting?

Zhengye Biotechnology held its 2026 Annual General Meeting on March 24, 2026, in Jilin City, China. Shareholders could attend in person or join virtually via a live audio webcast hosted at www.virtualshareholdermeeting.com/ZYBT2026.

How many Zhengye Biotechnology (ZYBT) shares were entitled to vote at the 2026 AGM?

At the close of business on February 12, 2026, Zhengye Biotechnology had 47,391,376 ordinary shares outstanding. Each share carried one vote, meaning all outstanding shares represented the company’s total voting power for the Annual General Meeting.

What quorum was present at Zhengye Biotechnology’s 2026 shareholder meeting?

A quorum was reached with holders of 43,133,362 ordinary shares represented in person or by proxy. This voting presence allowed the Annual General Meeting to proceed and for all resolutions on the agenda to be validly considered and decided.

How did shareholders of ZYBT vote on Resolution No. 1 at the 2026 AGM?

Resolution No. 1 at Zhengye Biotechnology’s 2026 Annual General Meeting received 43,092,532 votes for, 24,730 votes against, and 16,100 abstentions. These results indicate very strong shareholder support for the proposal associated with Resolution No. 1.

Were multiple resolutions approved at Zhengye Biotechnology’s 2026 AGM?

Shareholders voted on five numbered resolutions (Nos. 1–5) at the 2026 Annual General Meeting. Each resolution received a very large majority of votes cast in favor, with relatively few votes against or abstentions, indicating broad shareholder approval.

Who signed Zhengye Biotechnology’s report on the 2026 AGM results?

The report on Zhengye Biotechnology’s 2026 Annual General Meeting results was signed on behalf of the company by Chief Executive Officer Songlin Song. The signature confirms that an authorized executive certified the accuracy of the disclosed voting information.